4 min read
Diabetic Wound Healing in the GLP-1 Era: What Systemic Metabolic Control Does Not Solve
The GLP-1 receptor agonists have changed the trajectory of type 2 diabetes care, and the evidence now suggests their...
Sep 29, 2026by MD Biosciences
The GLP-1 receptor agonists have changed the trajectory of type 2 diabetes care, and the evidence now suggests their...
Sep 22, 2026by MD Biosciences
Postoperative pain management is in the middle of a reimbursement shift. Since January 2025, Medicare has paid...
Sep 16, 2026by MD Biosciences
Diabetic peripheral neuropathy affects nearly half of people living with diabetes, and it remains one of the harder...
Sep 1, 2026by MD Biosciences
For seventy years, antipsychotics for schizophrenia acted on dopamine and antidepressants acted on monoamines. The...
Aug 25, 2026by MD Biosciences
As of August 2026, acute post-surgical pain has an approved non-opioid sodium channel blocker and a second program with...